Molecular pathology and genetics of pancreatic endocrine tumours

Journal of Molecular Endocrinology
Gabriele CapursoGianfranco Delle Fave

Abstract

Pancreatic neuroendocrine tumours (PETs) are the second most frequent pancreatic neoplasms. Their poor chemosensitivity, high rate of metastatic disease and relatively long survival make PETs an ideal field to be explored for novel therapies based on specific molecular changes. PETs are generally sporadic but can also arise within hereditary syndromes, such as multiple endocrine neoplasia type 1, von Hippel-Lindau, neurofibromatosis type 1 and tuberous sclerosis complex, which represent a model for sporadic cases too. Among allelic imbalances, main genomic changes involve gain of 17q, 7q and 20q and loss of 11q, 6q and 11p, which identify regions of putative candidate oncogenes or tumour suppressor genes (TSGs), respectively, sometime with potential prognostic significance. Overexpression of Src-like kinases and cyclin D1 (CCND1) oncogene has been described. As for TSGs, P53 (TP53), DPC4/SMAD4 and RB (RB1) are not implicated in PET tumorigenesis, while for p16INK4a (CDKN2A), TIMP3, RASSF1A and hMLH1, more data are available, suggesting a role for methylation as a silencing mechanism. In the last decade, gene expression profile studies, analysis of microRNAs and, more recently, large-scale mutational analysis have highlighted co...Continue Reading

References

Jun 1, 1994·Annals of Surgery·B M EversJ C Thompson
Dec 24, 1997·Clinical Endocrinology·R L Rosenfield
Aug 5, 2000·Genes, Chromosomes & Cancer·E StumpfL C Andersson
Nov 30, 2000·The Journal of Clinical Endocrinology and Metabolism·J SerranoR T Jensen
Sep 11, 2001·Genes, Chromosomes & Cancer·P S MooreA Scarpa
Dec 18, 2001·Genes, Chromosomes & Cancer·J ZhaoP Komminoth
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Edoardo MissiagliaAldo Scarpa
May 9, 2002·Molecular and Cellular Endocrinology·Sydney S GuoMark P Sawicki
Oct 23, 2002·Clinical Endocrinology·B MukhopadhyayS L Chew
Oct 8, 2003·The Journal of Endocrinology·S S GuoM P Sawicki
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Donna E HanselAnirban Maitra
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura Rubbia-BrandtMichael S Pepper
Dec 14, 2004·Cancer Genetics and Cytogenetics·Giovanna FloridiaDomenica Taruscio
Feb 5, 2005·Molecular Cancer·William G DilleyTerry C Lairmore
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masayuki FurukawaRobert T Jensen
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Ying-Mai YangJie Chen
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Bettina PapouchadoRicardo V Lloyd
Jun 11, 2005·Endocrine-related Cancer·Y M H JonkersE-J M Speel
Oct 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Satyajit K KarnikSeung K Kim
Oct 26, 2005·Virchows Archiv : an International Journal of Pathology·Cinzia AzzoniCesare Bordi
May 30, 2006·Journal of Clinical Pathology·V HervieuJ-Y Scoazec
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claudia RoldoCarlo M Croce
Oct 17, 2006·Oncogene·J Averous, C G Proud
Nov 15, 2006·Annals of the New York Academy of Sciences·Christian A KochAndrea Tannapfel

❮ Previous
Next ❯

Citations

Aug 21, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Umashankar K Ballehaninna, Ronald S Chamberlain
Aug 14, 2012·Journal of Gastroenterology·Tetsuhide ItoRobert T Jensen
Nov 12, 2013·Current Problems in Surgery·Geoffrey W Krampitz, Jeffrey A Norton
Jul 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Peng ZhangXiaofeng Zhu
Dec 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ning QuYan Zhang
Jan 10, 2014·Cancer Medicine·Sara TesfazghiRenata Jaskula-Sztul
Jan 27, 2015·Journal of Hepato-biliary-pancreatic Sciences·Gabriele CapursoGianfranco Delle Fave
Feb 1, 2013·Expert Opinion on Pharmacotherapy·Tetsuhide ItoRobert T Jensen
Apr 4, 2015·Cancer Treatment Reviews·Franziska Briest, Patricia Grabowski
Aug 3, 2013·Molecular and Cellular Endocrinology·Alan Meeker, Christopher Heaphy
Dec 3, 2014·Seminars in Diagnostic Pathology·Chanjuan Shi, David S Klimstra
Feb 9, 2013·Seminars in Oncology·Emily K Bergsland
Jan 13, 2018·The Journal of Endocrinology·Andrea Mafficini, Aldo Scarpa
Jul 16, 2017·Endocrine-related Cancer·Annunziata Di DomenicoAurel Perren
Jan 8, 2019·Endocrine-related Cancer·Aura D Herrera-MartínezRichard A Feelders
Jan 19, 2019·Endocrine Reviews·Andrea Mafficini, Aldo Scarpa
Jul 6, 2014·European Journal of Gastroenterology & Hepatology·Dimitrios KarakaxasChristos Dervenis
Dec 31, 2019·Cell Cycle·Guergana Tchakarska, Brigitte Sola
Jun 17, 2020·Frontiers in Oncology·Martine BocchiniMassimiliano Mazza
Aug 21, 2020·Seminars in Cancer Biology·Manuel GentiluomoDaniele Campa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.